跳至主要内容
临床试验/CTRI/2026/03/106169
CTRI/2026/03/106169尚未招募不适用

Evaluation of the Add-on Effect of Marma Chikitsa on Talahridaya Marma Along With Standard Antihypertensive Drugs on Blood Pressure in Chronic Hypertensive Patients : A Randomized Controlled Trial

Dr Shubham Sanjay Zodpe1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2026年3月25日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
84
试验地点
1

研究概览

简要总结

This study is a prospective, randomized, double-blind, parallel-group clinical trial designed to evaluate the add-on effect of Talahridaya Marma Chikitsa along with standard antihypertensive drugs in patients with chronic hypertension. A total of 84 participants will be randomly allocated into intervention and control groups. The intervention group will receive Marma Chikitsa once daily for 10 days in addition to standard antihypertensive treatment, while the control group will receive standard treatment alone. Primary outcomes include changes in systolic and diastolic blood pressure, while secondary outcomes include pulse rate and symptom assessment using Visual Analog Scale.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Participant and Investigator Blinded

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Pre_diagnosed patients, SBP more than 139, DBP more than 89.

排除标准

  • Taking immunosuppressant, Taking oral contraceptives, Pregnancy associated hypertension.

研究者

发起方
Dr Shubham Sanjay Zodpe
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Shubham Zodpe

Shri Ayurved Mahavidyalaya Pakwasa Samanvaya Rugnalaya Nagpur

研究点 (1)

Loading locations...

相似试验